These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36583462)

  • 41. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
    Dos Santos L; Heineck I
    Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Off-Label and Unlicensed Drugs in Pediatric Palliative Care: A Prospective Observational Study.
    García-López I; Cuervas-Mons Vendrell M; Martín Romero I; de Noriega I; Benedí González J; Martino-Alba R
    J Pain Symptom Manage; 2020 Nov; 60(5):923-932. PubMed ID: 32569831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gaining insight into irrational off-label use of vidarabine through analysis of a spontaneous reporting system in China.
    Li H; Deng J; Yu P; Deng L; Ren X
    J Clin Pharm Ther; 2020 Dec; 45(6):1301-1311. PubMed ID: 32614099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Off-label drugs use in pediatric palliative care.
    De Zen L; Marchetti F; Barbi E; Benini F
    Ital J Pediatr; 2018 Nov; 44(1):144. PubMed ID: 30486873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use.
    Hughes ME; Landsburg DJ; Rubin DJ; Schuster SJ; Svoboda J; Gerson JN; Namoglu E; Nasta SD
    Clin Lymphoma Myeloma Leuk; 2019 Dec; 19(12):791-798. PubMed ID: 31648953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
    Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
    PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiological and Psychopharmacological Study About Off-Label Treatment in Child and Adolescent Psychiatric Emergencies: A Tertiary/Single Center Experience.
    Minghetti S; Vannini M; Casula L; Asprea M; Gori S; Calvani AM; Pisano T
    Pediatr Emerg Care; 2022 Nov; 38(11):e1660-e1663. PubMed ID: 35686968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.
    Prasad VK; Lucas KG; Kleiner GI; Talano JA; Jacobsohn D; Broadwater G; Monroy R; Kurtzberg J
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):534-41. PubMed ID: 20457269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
    Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
    Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expanded Access Programme: looking for a common definition.
    Iudicello A; Alberghini L; Benini G; Mosconi P
    Trials; 2016 Jan; 17():21. PubMed ID: 26758369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug utilization and off-label drug use among Spanish emergency room paediatric patients.
    Morales-Carpi C; Estañ L; Rubio E; Lurbe E; Morales-Olivas FJ
    Eur J Clin Pharmacol; 2010 Mar; 66(3):315-20. PubMed ID: 19936729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experience and prospects for the use of off-label drugs in oncology.
    Drogovoz SM; Starikov VI; Ivantsyk LB; Shchokina KG
    Exp Oncol; 2021 Mar; 43(1):1-5. PubMed ID: 33785726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychotropic Drug Prescription in Adolescents: A Retrospective Study in a Swiss Psychiatric University Hospital.
    Ansermot N; Jordanov V; Smogur M; Holzer L; Eap CB
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):192-204. PubMed ID: 29131655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Before It's Too Late: Multistakeholder Perspectives on Compassionate Access to Investigational Drugs for Pediatric Patients With Cancer.
    Gerasimov E; Donoghue M; Bilenker J; Watt T; Goodman N; Laetsch TW
    Am Soc Clin Oncol Educ Book; 2020 May; 40():1-10. PubMed ID: 32412804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
    Lee JL; Redzuan AM; Shah NM
    Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
    Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
    Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan.
    Aamir M; Khan JA; Shakeel F; Asim SM
    Int J Clin Pharm; 2017 Aug; 39(4):860-866. PubMed ID: 28597174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey.
    Roila F; Ballatori E; Labianca R; De Braud F; Borgonovo K; Martelli O; Gallo C; Tinazzi A; Perrone F;
    Tumori; 2009; 95(6):647-51. PubMed ID: 20210223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.